Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Lalande Kevin M., Director. Officer active across 3 companies, notably LUMOS PHARMA, INC.. Aggregated, 11 reports have been recorded. Split: 8 buys · 0 sell. Total volume traded: €1m. Activity tracked since 20 May 2021. The latest transaction was filed on 2 April 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lalande Kevin M.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.